Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome : A case report - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue American Journal of Tropical Medicine and Hygiene Année : 2005

Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome : A case report

Résumé

Strongyloides stercoralis hyperinfection syndrome due to the acceleration of the autoinfective cycle of the nematode is a life-threatening form of the infection occurring in immunocompromised hosts. Intestinal ileus, which is commonly encountered in this form, may reduce the bioavailability and thus the efficacy of oral anthelminthic drugs used in the treatment of the S. stercoralis hyperinfection syndrome. We report the efficacy and safety of subcutaneous administration of ivermectin in a patient infected with human T cell lymphotropic virus type I with S. stercoralis hyperinfection syndrome who was unresponsive to an oral combination of ivermectin and albendazole.
Fichier non déposé

Dates et versions

hal-02681829 , version 1 (31-05-2020)

Identifiants

  • HAL Id : hal-02681829 , version 1
  • PRODINRA : 142698
  • WOS : ISI:000230451900025

Citer

Jérôme Pacanowski, Marie dos Santos, Antoine Roux, Christine Le Maignan, Jacques Guillot, et al.. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome : A case report. American Journal of Tropical Medicine and Hygiene, 2005, 73 (1), pp.122-124. ⟨hal-02681829⟩
24 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More